31 related articles for article (PubMed ID: 22759219)
1. Thermochemotherapy in hereditary retinoblastoma.
Schueler AO; Jurklies C; Heimann H; Wieland R; Havers W; Bornfeld N
Br J Ophthalmol; 2003 Jan; 87(1):90-5. PubMed ID: 12488270
[TBL] [Abstract][Full Text] [Related]
2. Ocular Salvage and Vision Preservation Using a Topotecan-Based Regimen for Advanced Intraocular Retinoblastoma.
Brennan RC; Qaddoumi I; Mao S; Wu J; Billups CA; Stewart CF; Hoehn ME; Rodriguez-Galindo C; Wilson MW
J Clin Oncol; 2017 Jan; 35(1):72-77. PubMed ID: 28034080
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma Based on Patient Age in 964 Eyes of 554 Patients.
Bas Z; Dalvin LA; Tadepalli S; Rao R; Shah A; Leahey AM; Shields CL
Asia Pac J Ophthalmol (Phila); 2021 Jan; 10(4):373-380. PubMed ID: 33481399
[TBL] [Abstract][Full Text] [Related]
4. Improving survival of retinoblastoma in Uganda.
Waddell KM; Kagame K; Ndamira A; Twinamasiko A; Picton SV; Simmons IG; Revill P; Johnston WT; Newton R
Br J Ophthalmol; 2015 Jul; 99(7):937-42. PubMed ID: 25583281
[TBL] [Abstract][Full Text] [Related]
5. HDAC6 inhibitor WT161 induces apoptosis in retinoblastoma cells and synergistically interacts with cisplatin.
Sun J; Qian X; Zhang F; Tang X; Ju C; Liu R; Zhou R; Zhang Z; Lv XB; Zhang C; Huang G
Transl Cancer Res; 2019 Dec; 8(8):2759-2768. PubMed ID: 35117033
[TBL] [Abstract][Full Text] [Related]
6. Clinical spectrum and treatment outcome of retinoblastoma with Group D and E diseases: A single institution retrospective review.
Weng PY; Chen SH; Kao LY; Tsai YJ; Yang SH; Tseng CK; Tsay PK; Jaing TH
Medicine (Baltimore); 2020 Sep; 99(38):e22201. PubMed ID: 32957352
[TBL] [Abstract][Full Text] [Related]
7. Effects of matrine on the proliferation and apoptosis of vincristine-resistant retinoblastoma cells.
Zhao B; Li B; Liu Q; Gao F; Zhang Z; Bai H; Wang Y
Exp Ther Med; 2020 Sep; 20(3):2838-2844. PubMed ID: 32765780
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA PLAC2 regulates PTEN in retinoblastoma and participates in the regulation of cancer cell apoptosis.
Song L; Qi Y; Lin M
Oncol Lett; 2020 Mar; 19(3):2489-2494. PubMed ID: 32194749
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA BANCR regulates growth and metastasis and is associated with poor prognosis in retinoblastoma.
Su S; Gao J; Wang T; Wang J; Li H; Wang Z
Tumour Biol; 2015 Sep; 36(9):7205-11. PubMed ID: 25894373
[TBL] [Abstract][Full Text] [Related]
10. Trilateral retinoblastoma.
Antoneli CB; Ribeiro Kde C; Sakamoto LH; Chojniak MM; Novaes PE; Arias VE
Pediatr Blood Cancer; 2007 Mar; 48(3):306-10. PubMed ID: 16572402
[TBL] [Abstract][Full Text] [Related]
11. Continuing challenges in the management of retinoblastoma with chemotherapy.
Shields CL; Meadows AT; Leahey AM; Shields JA
Retina; 2004 Dec; 24(6):849-62. PubMed ID: 15579981
[TBL] [Abstract][Full Text] [Related]
12. The treatment of retinoblastoma with four-drug regimen including cisplatin, etoposide, vincristine, and cyclophosphamide.
Varan A; Kiratli H; Aydın B; Tarlan B; Poyraz CB; Akyüz C; Büyükpamukçu M
Pediatr Hematol Oncol; 2012 Sep; 29(6):529-37. PubMed ID: 22759219
[TBL] [Abstract][Full Text] [Related]
13. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
14. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
[TBL] [Abstract][Full Text] [Related]
15. Management and outcome of retinoblastoma with vitreous seeds.
Manjandavida FP; Honavar SG; Reddy VA; Khanna R
Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
